Proceedings of the Royal Society of Medicine 1 2 Treatment.-Isoniazid-dosage: 200 mg. daily for two weeks and then 300 mg. daily for two months. There was marked improvement after six weeks. All the nodules had flattened and scaling had occurred. After four months' treatment there are one or two pigmented macules in the scar. No toxic effects. Case V.-L. H., female, aged 63.
History.-Duration of lupus vulgaris on the left cheek: forty-seven years. She was first seen in 1944 when she had an irregular scarred area on the left cheek with nodules at the edge and in the centre of the scar.
Treatment.-June 1944 to July 1950: Calciferol therapy with rest periods. She never developed signs of toxicity nor was there much improvement.
July 1950: Streptomycin and PAS. After a six weeks' course there was slight flattening of the nodules.
August 1951 to May 1952: Thiosemicarbazone 200 mg. daily. After two months' treatment there was some improvement but despite continued treatment new nodules appeared in the centre of the scar.
June 1952: Isoniazid commenced with a dosage of 200 mg. daily for the first two months, and then 300 mg. daily for a further two months.
Progress.-After one month all the nodules had flattened and their surface became scaly. Improvement was maintained and after fifteen weeks' treatment she developed erythema nodosum on both lower legs and simultaneously the left cheek became swollen and red. Treatment was stopped and this reaction subsided in three weeks. The lupus vulgaris appeared to be clinically inactive and only pigmented macules were present in the scarred area. She has had no treatment for the past two months. There have been no signs of toxicity.
Case VI.-Mrs. M. M., aged 67. History.-Large sheet of lupus starting in childhood, and involving the right side of the face. Intermittent treatment with calciferol since 1946. This had to be discontinued on several occasions because of nausea and vomiting and urinary symptoms. The lupus improved but many active nodules persisted in the scar.
Treatment.-Course of isoniazid: At the beginning of treatment, a crop of raised lupus nodules was scattered throughout the scar tissue. Response was rapid and at the end of four months' treatment no infiltrated nodules remained and only a few pigmented macules were present. No toxic effects.
Dosage: 300 mg. daily.
Comment.-We have presented 6 out of 15 cases of lupus vulgaris which have been treated for at least four months with isoniazid. Of these 15 cases all except one had previously received calciferol for a prolonged period and had either relapsed or had proved resistant to the treatment. Some had also been treated in addition with streptomycin and with thiosemicarbazone. The dosage of isoniazid was initially 3 mg. per kg. body-weight per day but after two-months this was increased to 6 mg.
Results.-All the cases, with the exception of one patient on,whom treatment was abandoned because of toxic effects, showed striking improvement within one month. Nodules arising in scarred areas rapidly flattened. After four months' treatment only 2 cases showed any clinical evidence of aetivity.
Toxicity.-Toxic effects occurred in 4 patients. One patient developed severe vertigo and a coarse tremor of the hands within a week. After a rest of two weeks a dose of 50 mg. per day was tried but the symptoms returned and treatment was abandoned.
The second patient developed extreme fatigue and numbness of the head after two months' treatment with a dose of 3 mg. per kg. Her lupus was at that time clinically inactive and treatment was stopped. She has been followed for a period of three months and no relapse has occurred.
The third patient developed fatigue and an enormous appetite and put on a stone in weight after being treated for seven weeks. The lupus had improved but there were still signs of activity.
The fourth (Case V) developed erythema nodosum on the legs and swelling and congestion of the lupus area after fifteen weeks' treatment. This reaction subsided within three weeks and the lupomata had flattened, leaving pigmented macules in the scar. History.-For the past twenty-one years the patient has had a slowly growing area of lupus vulgaris of the skin over his epiglottis. Ten months ago he noticed a lump in his hard palate, and biopsy at the Institute of Dental Surgery showed this to be lupus. Mr. D. Downton therefore referred him to St. Johns' Hospital for treatment.
1912: Small area of lupus on the lower part of left leg, clearing with "blue ointment" in one and a half years at age of 7. 1929: Area of lupus vulgaris under chin "following blow on tuberculous gland of neck" one year previously. Lesion cleared; cauterized and general ultraviolet light given for six months. 1931: Patient noticed onset of lesion over epiglottis (vide suipra). 1937: Abscess left buttock and outer right thigh, leading to the diagnosis of tuberculous spine.
On examnination.-A typical lesion of lupus can be seen over the epiglottis measuring 3-8 x 3.8 cm. Under the chin there is a scarred area of older lupus which contains active nodules. On the right side of the hard palate a pale brown infiltrated area is present measuring 0 3 x 0-6 cm.
Special investigations.-X-ray chest: shows adhesions at the right lung base and a healed calcified shadow in the left middle zone. There is no evidence of any active lung disease.
Mantoux: 1: 10,000 negative. 1: 1,000 positive. T/eatment.-Treatment with isoniazid (100 mg. t.d.s.) was started six months ago. All the active lesions looked paler and flatter at the third week. After six weeks' therapy there were no signs of the palatal lesion and only a few ghost lesions could be seen on the neck. These latter have disappeared following a three months' course of calciferol (100,000 i.u. daily) and a further six weeks' isoniazid (150 mg. three times daily).
Conm1aent.-Calciferol was given as an alternative therapy as it was thought that the tendency for developing drug resistance would be reduced by limiting the length of the courses.
The President: We have shown these cases, not because we suppose that we have had more experienice of the treatment of lupus with isoniazid than many others, but with the intention of comparing notes. The drug Nydrazid (isoniazid) was made freely available to us at St. Thomas's Hospital at the earliest possible moment through the kindness of Dr. Geoffrey Rake.
In addition to the 15 cases so far treated at St. Thomas's, 4 in-patients have been treated at the Morland Clinics at Alton, 2 previously untreated and 2 old cases which had been treated both locally and with calciferol. All 4 were clinically cured within less than four months, that is, none of the characteristic lupomatous nodules can now be seen. One case of severe senile tuberculous adenitis with multiple discharging sinuses, treated in the out-patient department at St. Thomas's Hospital, has cleared up completely in about the same period.
The speed and reliability of this treatment have greatly exceeded that of calciferol and of calciferol combined with streptomycin, while with thiosemicarbazone we never achieved any striking degree of success. We are now abandoning treatment for new cases with isoniazid alone in favour of the treatment advocated by Joiner and others (1952, Lancet, ii, 843) , that is the combination of isoniazid and streptomycin. Dr. Brian Russell and Dr. N. A. Thorne: Progress Repor-t o01 15 Cases Dr. Brian Russell: We wish to make a progress report on 15 patients who have been treated with isoniazid for periods varying between nine and thirty weeks. We have adopted strict criteria of improvement-it is only permissible to contemplate the possibility of "cure" of lupus after all physical signs of activity have been absent for at least five years. After clinical cures from all forms of treatment used up to the present, biopsies have sometimes revealed the presence of tubercles in apparently healed areas. Time alone can tell whether isoniazid will prove the exception by removing histological as well as clinical evidence of tuberculosis.
In our trial, then, clinical clearance is taken to mean the disappearance of all redness, infiltration, scaling and "apple-jelly" nodulation. If the faintest scaling or brownish discoloration remains at the site of a nodule, progress has been described as marked (3 +). If there is slight residual infiltration, with scaling and increased opacity of the lesions the grading has been moderate improvement (2 +). Slight improvement (1 +) infers a diminution of redness, infiltration, scaling and translucency. All observations of progress have been controlled by photographs, using the same factors of lighting, exposure, &c., throughout.
The minimal reasonably effective dose for an adult seems to be 100 mg. three times a day and we have given 100 mg. four times a day to some patients who have not responded well enough to the smaller dosage. We have given the drug orally or by -local intralesional injections or by a combination of these methods. With oral treatment, a steady and quiet improvement takes place, without early exacerbations such as are often observed with calciferol. The effect of isoniazid seems to be on the organisms and that of calciferol on the host and there seems no reason why the two treatments should not be given together if desired.
